Media
News and Publications
Find out about the latest news, announcements, and research from IMIDomics.
scroll down
latest news
In the News
Dec 7, 2022
IMIDomics Announces Appointment of Key Science and Medical Research Experts to Newly Formed Immunology Advisory Board
Businesswire.comIn the News
Mar 23, 2022
CataloniaBio & HealthTech has awarded IMIDomics with the Bioèxit Award | Award acceptance speech by co-founder and CMO, Dr. Sara Marsal
Cataloniabioht.orgIn the News
Feb 15, 2022
IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE
Businesswire.comIn the News
Oct 7, 2021
IMIDomics sponsors the online Symposium “Combination therapies in common diseases: clinical and translational challenges”, October 7th 2021
Doctis.euIn the News
Jul 27, 2021
IMIDomics™ Closes $16.5 Million Series A Financing to Advance its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases
Businesswire.comIn the News
Jul 20, 2021
IMIDomics co-organizes symposium "Combination therapies in common diseases: clinical and translational challenges"
Doctis.euIn the News
Oct 16, 2020
Drug candidate for severe COVID-19 identified by IMIDomics and VHIR Rheumatology Group selected for NIH clinical trial
Nih.govIn the News
May 20, 2020
IMIDomics funds a study that identifies a new drug candidate to prevent severe COVID-19
Arxiv.orgIn the News
Feb 2, 2020
IMIDomics and Gossamer Bio Enter into a Strategic Collaboration to Advance the Development of Novel Treatments for Patients with Immune-Mediated Inflammatory Diseases
Businesswire.comIn the News
Dec 1, 2019
IMIDomics granted Horizon 2020 project on Systems approaches for the discovery of combinatorial therapies for complex disorders
Doctis.euOops! Something went wrong while submitting the form.